Previous 10 | Next 10 |
home / stock / bvaxf / bvaxf news
BioVaxys and Procare Health Execute US Distribution Agreement for Papilocare Gel and Oral Immunocaps Canada NewsWire VANCOUVER , British Colombia and BARCELONA, Spain , Dec. 19, 2022 /CNW/ - BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ...
BioVaxys Co-Founder, President and Chief Operating Officer Kenneth Kovan to Present at MedInvest Oncology Investor Conference Canada NewsWire VANCOUVER, BC , Dec. 5, 2022 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxy...
Palm Beach, FL – December 1, 2022 – FinancialNewsMedia.com News Commentary – The global ovarian cancer market is projected to continue to grow through the coming several years. The formation of mutational cells or tissues in female reproductive organs called ovari...
BioVaxys Announces Successful Test-Run Production of its Bi-Haptenized Ovarian Cancer Vaccine Canada NewsWire VANCOUVER, BC , Dec. 1, 2022 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") is pleased to announ...
BioVaxys Sarbecovirus Vaccine Interim Data Excellent Emerging Safety & Tolerability Profile with BVX-1021 BioVaxys Sarbecovirus Vaccine Interim Data Excellent Emerging Safety & Tolerability Profile with BVX-1021 Canada NewsWire VANCOUVER, BC , Nov...
BIOVAXYS ANNOUNCES COMPLETED PRIVATE PLACEMENT AND DEBT SETTLEMENT Canada NewsWire VANCOUVER, BC , Nov. 10, 2022 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ( "BioVaxys" or the "Company") announces that it has completed...
BIOVAXYS ANNOUNCES DEBT SETTLEMENT Canada NewsWire VANCOUVER, BC , Oct. 6, 2022 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ( "BioVaxys" or the "Company") announces that it has agreed to settle an aggregate of $300,...
Palm Beach, FL – October 6, 2022 – FinancialNewsMedia.com News Commentary – The global Cervical Cancer Treatment market has been expanding for several years and is projected to continue at a growing CAGR. Cervical Cancer is a cancer arising from the cervix w...
BioVaxys Executes Binding Term Sheet for the US Marketing & Distribution for Papilocare Gel and Oral Immunocaps BioVaxys Executes Binding Term Sheet for the US Marketing & Distribution for Papilocare Gel and Oral Immunocaps Canada NewsWire Agreement Include...
BioVaxys Further Expands Vaccines Intellectual Property Portfolio Canada NewsWire VANCOUVER, BC , Sept. 28, 2022 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") announced today that in an action that...
News, Short Squeeze, Breakout and More Instantly...
Biondvax Pharms Ltd Ord Company Name:
BVAXF Stock Symbol:
OTCMKTS Market:
Biondvax Pharms Ltd Ord Website:
BioVaxys Technology Corp. Announces Failure to File Cease Trade Order Canada NewsWire VANCOUVER, BC , May 16, 2024 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the " Company ") announces that the Ontario Securities Commission (the...
Biotech Innovations Aim to Combat Soaring Cancer Diagnoses by 2050 Canada NewsWire USA News Group Commentary Issued on behalf of BioVaxys Technology Corp. VANCOUVER, BC , May 1, 2024 /CNW/ -- USA News Group ...
BIOVAXYS APPOINTS CHRISTOPHER CHERRY AS CHIEF FINANCIAL OFFICER Canada NewsWire VANCOUVER, BC , April 30, 2024 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the " Company ") is pleased to announce that it has appointed Chris...